NCT05187325 is a clinical trial of no intervention in Temporomandibular Joint Disorders, sponsored by Kanuni Sultan Suleyman Training and Research Hospital.

Who is sponsoring NCT05187325?

NCT05187325 is sponsored by Kanuni Sultan Suleyman Training and Research Hospital.

What drugs are being tested in NCT05187325?

Interventions in NCT05187325: no intervention.

What condition does NCT05187325 study?

NCT05187325 studies Temporomandibular Joint Disorders, Myofascial Trigger Point Pain, Jaw Diseases, Pain.

Is NCT05187325 still recruiting?

NCT05187325 is currently completed. Last updated 31 March 2022.

Last reviewed 2022-03-31 · How we verify

NCT05187325

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Clinical Effects of Myofascial Trigger Points in Disc Replacement With Reduction

Completed Last updated 31 March 2022

What this trial tests

trial testing no intervention in Temporomandibular Joint Disorders in 120 participants. Completed in 17 February 2022.

Timeline

15 December 2021

Primary endpoint
15 February 2022

17 February 2022

Quick facts

Lead sponsor	Kanuni Sultan Suleyman Training and Research Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	120
Start date	15 December 2021
Primary completion	15 February 2022
Estimated completion	17 February 2022
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

no intervention

Conditions studied

Temporomandibular Joint Disorders — all drugs for Temporomandibular Joint Disorders →
Myofascial Trigger Point Pain — all drugs for Myofascial Trigger Point Pain →
Jaw Diseases — all drugs for Jaw Diseases →
Pain — all drugs for Pain →

Sponsor

Kanuni Sultan Suleyman Training and Research Hospital

Who can join

Adults 18 to 65, any sex, with Temporomandibular Joint Disorders or Myofascial Trigger Point Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective, and controlled trial. 60 participants with myofascial trigger points and disc displacement with reduction and 60 participants with disc displacement with reduction will be included in the study. These two groups will be compared for clinical findings, pain severity and limitation of the temporomadibular function.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Do myofascial trigger points in masseter muscles affect the symptoms of disc displacement with reduction? A cross-sectional study.
Korkmaz MD, Karacay BC. · · 2023 · cited 1× · PMID 37971122 · DOI 10.1590/1806-9282.20230622

Verify or expand the search:

Other trials of no intervention

Trials testing the same drug.

NCT07480057 — Assessment of Changes in Bone Mineral Metabolism After Liver Transplantation by Bone Mineral Densitometry · recruiting
NCT07253506 — Turkish Adaptation, Validity, and Reliability Study of the Patient Experience With Treatment and Self-Management Scale i · not yet recruiting
NCT07253519 — The Relationship Between Mood and Insomnia Severity and Caregiver Burden in Caregivers of Stroke · not yet recruiting
NCT07194096 — Stress Hyperglycemia Ratio and Postoperative Delirium · not yet recruiting
NCT07240337 — Botulinum Toxin Applications in Hemiplegic Patients · recruiting

Other recruiting trials for Temporomandibular Joint Disorders

Currently open trials in the same condition.

NCT07317570 — The Effect of Body Awareness Therapy on Pain, Function and Psychosocial Parameters in Temporomandibular Joint Disorders · NA · recruiting
NCT06763419 — Internal Photobiomodulation For Management Of Temporomandibular Joint Internal Derangement · NA · recruiting
NCT06721104 — Balance, TMJ, Social Adaptive Assessment in Individuals With Autism Spectrum Disorder · recruiting
NCT06500390 — Temporomandibular Disorder in Use of Levonorgestrel Intrauterine System · NA · recruiting
NCT06813040 — Efficacy of Repetitive Transcranial Magnetic Stimulation in Temporomandibular Disorders. · NA · recruiting

Other Kanuni Sultan Suleyman Training and Research Hospital trials

Trials by the same sponsor.

NCT07519551 — Serum Myostatin and Irisin Levels in Postmenopausal Women: Association With Bone Mineral Density and Muscle Strength · not yet recruiting
NCT07480330 — Serum Neurofilament Light Chain Levels and Neuropathy Severity in Diabetic Polyneuropathy · not yet recruiting
NCT07425405 — Daily Screen Exposure and Preoperative Anxiety in Children Aged 2-5 Years · recruiting
NCT07358754 — The Relationship Between Serum S100B and Brain-Derived Neurotrophic Factor · recruiting
NCT07261436 — Performance Comparison of Large Language Models in TAP Block Ultrasound Interpretation · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05187325 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Kanuni Sultan Suleyman Training and Research Hospital
Last refreshed: 31 March 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05187325.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing